logo
From γ-carboxy-glutamate to protein C
Value of D-dimer testing to decide duration of anticoagulation after deep vein thrombosis
Value of D-dimer testing to decide duration of anticoagulation after deep vein thrombosis
Allosteric disulfide bonds in thrombosis and thrombolysis
Platelet activation and cardiovascular outcomes in acute coronary syndromes
Platelet hyperactivity and risk of recurrent thrombosis
Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS
On the cutting edge
von Willebrand factor and its propeptide
Tackling the diabetic platelet
Diabetes mellitus and platelet function after administration of aspirin and a single 600 mg dose of clopidogrel
Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome
Incidence of inhibitors in a cohort of 838 males with hemophilia A previously treated with factor VIII concentrates
Prothrombin A19911G polymorphism and the risk of venous thromboembolism
The association of prothrombin A19911G polymorphism with plasma prothrombin activity and venous thrombosis
Inhibition of tissue factor expression by hydroxyurea in polymorphonuclear leukocytes from patients with myeloproliferative disorders
Low ankle–brachial index predicts an adverse 1-year outcome after acute coronary and cerebrovascular events
Differential regulation of protein S expression in hepatocytes and sinusoidal endothelial cells in rats with cirrhosis
A novel missense mutation responsible for factor VII deficiency in research Beagle colonies
Severe prothrombin deficiency caused by prothrombin-Edmonton (R-4Q) combined with a previously undetected deletion
Plasma hemostatic factors and endothelial markers in four racial/ethnic groups
von Willebrand factor activates endothelial nitric oxide synthase in blood platelets by a glycoprotein Ib-dependent mechanism
Inhibition of adhesive and signaling functions of the platelet GPIb-V-IX complex by a cell penetrating GPIbα peptide
Thrombin-triggered platelet apoptosis
Bax activators potentiate coated-platelet formation
Preconditioning ischemia attenuates molecular indices of platelet activation-aggregation
Early growth response transcription factor EGR-1 regulates Gαq gene in megakaryocytic cells
Prothrombotic factors enhance heparin-induced thrombocytopenia and thrombosis in vivo in a mouse model
PAR-1-dependent pp60src activation is dependent on protein kinase C and increased [Ca 2+]i
Distribution and dynamic changes of sphingolipids in blood in response to platelet activation
Effect of pharmacologic plasminogen activator inhibitor-1 inhibition on cell motility and tumor angiogenesis
Flow-based assays for global assessment of hemostasis. Part 2
Soluble CD40 ligand in asthma patients during allergen challenge
Estimation of a potentially preventable fraction of venous thromboembolism
A Bβ 14 Arg → Cys fibrinogen variant in a patient with thrombotic complications (fibrinogen St-Germain III)
Pregnancy loss, tissue factor pathway inhibitor deficiency and resistance to activated protein C
What causes the enhancement of activity of factor VIIa by tissue factor?
PAR-1 activation has different effects on the angiogenic activity of endothelial progenitor cells derived from human adult and cord blood
Who is at risk for occult cancer after venous thromboembolism?
Full evaluation of an acquired case of thrombotic thrombocytopenic purpura following the surgical resection of glioblastoma multiforme
More on
TALKING ABOUT…
CORRIGENDUM
ANNOUNCEMENTS